案例系列首次微侵袭性全内镜使用新 mitra 假肢
Jacqueline Kruse1, Miriam Silaschi1, Kristina Russu1
1Department of Cardiac Surgery, Heart Center Bonn, University Hospital Bonn, 53127 Bonn, Germany.
Journal of clinical medicine
|August 10, 2024
概括
新型爱德华兹MITRIS RESILIA中膜对需要更换门的年轻患者来说是有前途的,提供了更好的耐用性和血液动力学. 这项研究证明了通过微创内镜方法安全植入.
科学领域:
- 心血管外科心血管外科
- 生物医学工程 生物医学工程
- 医疗成像医学成像
背景情况:
- 在年轻患者中,越来越多地使用生物假体关节.
- 门的恶化是一个显著的风险,特别是在关节位置.
- 爱德华兹 MITRIS RESILIA门旨在提高耐用性和血液动力学.
研究的目的:
- 为了报告爱德华兹的植入 MITRIS RESILIA mitra 门.
- 通过微创全内镜访问来评估其使用.
- 在一系列12名患者中评估门的性能和安全性.
主要方法:
- 在患者评估中使用了手术前的对比增强ECG-gatedCT扫描.
- 心脏CT软件模拟了假肢放置,并测量了左心室外流管 (LVOT) 的变化.
- 爱德华兹 MITRIS RESILIA 门已在 12 名患者身上植入,使用完全内镜的微创手术技术与 3D 可视化.
主要成果:
- 该研究包括12名患者 (平均年龄为56.5岁),其中58.33%接受了重复手术.
- 所有患者在手术后的30天内都存活下来,平均交叉合时间为40.17分钟.
- 没有出现膜外泄或LVOT阻塞;平均术后梯度为4.45mmHg.
结论:
- 爱德华兹 MITRIS RESILIA 关节是一种有前途的关节置换生物假体.
- 与现有的假肢相比,它有可能提高耐用性和血液动力学.
- 门的柔性和设计使其更容易植入,简短的操作时间证明了这一点.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


